These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2079659)
1. Application of the NONMEM method to evaluation of the bioavailability of drug products. Kaniwa N; Aoyagi N; Ogata H; Ishii M J Pharm Sci; 1990 Dec; 79(12):1116-20. PubMed ID: 2079659 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the standard approach and the NONMEM approach in the estimation of bioavailability in man. Combrink M; McFadyen ML; Miller R J Pharm Pharmacol; 1997 Jul; 49(7):731-3. PubMed ID: 9255720 [TBL] [Abstract][Full Text] [Related]
3. Application of NONMEM method for evaluation of relative biological availability of ofloxacin. Li Z; Chen G; Zhuo HT Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):39-42. PubMed ID: 8010083 [TBL] [Abstract][Full Text] [Related]
4. Alternative approach to relative bioavailability and bioequivalence evaluation, with drugs following Michaelis-Menten elimination kinetics. Fagiolino P; Stareczek S Farmaco; 1990 Sep; 45(9):1027-36. PubMed ID: 2282123 [TBL] [Abstract][Full Text] [Related]
5. Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study. Rojanasthien N; Chaichana N; Teekachunhatean S; Kumsorn B; Sangdee C; Chankrachang S J Med Assoc Thai; 2007 Sep; 90(9):1883-93. PubMed ID: 17957935 [TBL] [Abstract][Full Text] [Related]
6. Comparison on bioequivalence of four phenytoin preparations in patients with multiple-dose treatment. Tsai JJ; Lai ML; Yang YH; Huang JD J Clin Pharmacol; 1992 Mar; 32(3):272-6. PubMed ID: 1564132 [TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study. Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688 [TBL] [Abstract][Full Text] [Related]
8. Bioequivalence evaluation of a triamterene-hydrochlorothiazide generic product: a new bioequivalence index for fixed-dose combinations. Hamidi M; Shahbazi MA; Azimi K Regul Toxicol Pharmacol; 2011 Feb; 59(1):149-56. PubMed ID: 21193005 [TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability study of doxycycline hyclate (equivalent to 100 mg doxycycline) capsules (doxycin vs vibramycin) for bioequivalence evaluation in healthy adult volunteers. Alsarra IA; Al-Said MS; Al-Khamis KI; Niazy EM; El-Sayed YM; Al-Rashood KA; Al-Yamani MJ; Al-Balla SA Int J Clin Pharmacol Ther; 2004 Jul; 42(7):373-7. PubMed ID: 15605689 [TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability study of cefixime (equivalent to 100 mg/5 ml) suspension (Winex vs Suprax) in healthy male volunteers. Asiri YA; Al-Said MS; Al-Khamis KI; Niazy EM; El-Sayed YM; Al-Rashood KA; Al-Yamani MJ; Alsarra IA; Al-Balla SA Int J Clin Pharmacol Ther; 2005 Oct; 43(10):499-504. PubMed ID: 16240707 [TBL] [Abstract][Full Text] [Related]
11. Is Bioequivalence Established Based on the Reference-Scaled Average Bioequivalence Approach Relevant to Chronic Administration of Phenytoin? Perspectives Based on Population Pharmacokinetic Modeling and Simulations. Kim H; Fang L; Yu J; Meng Z; Trame MN; Schmidt S; Lesko LJ; Zhao L J Clin Pharmacol; 2019 Aug; 59(8):1061-1069. PubMed ID: 30716169 [TBL] [Abstract][Full Text] [Related]
12. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers. Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers. Lin H; Tian Y; Tian JX; Zhang ZJ; Mao GG Arzneimittelforschung; 2010; 60(3):162-7. PubMed ID: 20422949 [TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers. Palma-Aguirre JA; Lopez-Gamboa M; Cariño L; Burke-Fraga V; González-de la Parra M Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793 [TBL] [Abstract][Full Text] [Related]
15. Application of routine monitoring data for determination of the population pharmacokinetics and enteral bioavailability of phenytoin in neonates and infants with seizures. Al Za'abi M; Lanner A; Xiaonian X; Donovan T; Charles B Ther Drug Monit; 2006 Dec; 28(6):793-9. PubMed ID: 17164696 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioequivalence study of two mosapride citrate formulations after single-dose administration in healthy Chinese male volunteers. Huang J; Tian Y; Zhang ZJ; Li J; Cao X Arzneimittelforschung; 2011; 61(3):167-72. PubMed ID: 21528641 [TBL] [Abstract][Full Text] [Related]
17. [Testing of bioequivalence of a new sotalol hydrochloride preparation in comparison to a standard formulation]. Herrmann R; Kleinbloesem CH Arzneimittelforschung; 1995 Aug; 45(8):849-52. PubMed ID: 7575745 [TBL] [Abstract][Full Text] [Related]
18. Comparative bioavailability of two tablet formulations of metoclopramide hydrochloride. el-Sayed YM; Niazy EM; al-Rayes S; Ismail AO; Gouda MW Int J Clin Pharmacol Ther; 1995 Mar; 33(3):136-9. PubMed ID: 7599911 [TBL] [Abstract][Full Text] [Related]
19. Bioequivalence study of a fixed dose combination of nitazoxanide and ofloxacin in Indian healthy volunteers. Agarwal S; Solomon WD; Gowda KV; Selvan PS; Ghosh D; Sarkar AK; Chattaraj TK; Pal TK Arzneimittelforschung; 2007; 57(10):679-83. PubMed ID: 18074762 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter. Vlase L; Bodiu B; Leucuta SE Arzneimittelforschung; 2005; 55(11):664-8. PubMed ID: 16366040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]